Using the shot

Ozari Health vs Coby Health

$125/mo against $239/mo for tirzepatide. Which is worth it, and for whom.

Updated 2026-09-18

How we are paid: one company on this page — Coreage Rx — pays us a commission if you sign up through our link. It does not buy a better score, a higher position, or the removal of a single criticism. Our rating method and full disclosure are both public.


Both sell tirzepatide. Ozari Health costs $125 a month and Coby Health costs $239, a difference of $114 a month or about $1,368 a year. The other differences matter more than the money if this is your first course.

Ozari Health is lowest advertised semaglutide price. Coby Health is multi-month value with supplies included. They are not aimed at the same person, and the cheaper one is not automatically the right answer — particularly if this is your first course and you expect a slow titration.

Side by side

Ozari HealthCoby Health
Advertised from$125$179
Membership on topNoneNone
True monthly cost$125$239
Roughly, per year$1,500$2,868
Price includes medicationYesYes
Names its pharmacyNot publishedNot published
Our score4.4 / 53.6 / 5

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The differences that affect treatment

On every attribute we track these two behave identically — same answer on dose pricing, commitment, pharmacy disclosure, formats, insurance and what the price includes. When that happens the decision really is just the monthly figure, and Ozari Health is $114 a month cheaper.

What each programme publishes: Ozari Health

  • Compounded semaglutide advertised from $86/month — the lowest verified rate in this comparison.
  • Compounded tirzepatide advertised from $125/month.
  • No membership fee; free expedited 3-5 day shipping included.
  • HSA and FSA accepted; no insurance billing.
  • Physician review through Arora Health, the same clinical network behind Trimi, with named medical directors.
  • States on its own pages that compounded medications are not FDA-approved.
  • Publishes verbatim Trustpilot reviews rather than curated testimonials.

Where it wins: The lowest advertised compounded semaglutide price we have verified. Watch for: Confirm whether $86 is a month-to-month rate or requires a longer commitment, and ask which pharmacy compounds it.

What each programme publishes: Coby Health

  • Compounded tirzepatide listed at $239/month on the monthly plan, down from $299.
  • Multi-month plans bring compounded tirzepatide to about $179/month.
  • An at-home injection kit with alcohol pads and syringes is included.
  • Monthly plans can be cancelled at any time.
  • States plainly on its own product pages that compounded medication is not FDA-reviewed or approved.

Where it wins: Injection supplies are included rather than something you source yourself. Watch for: The $179 figure is a multi-month rate. Month-to-month is $239.

Strengths of each

Ozari Health.

  • The lowest advertised compounded semaglutide price we have verified.
  • No membership fee and free expedited shipping included.
  • Names its physician network and medical directors.

Coby Health.

  • Injection supplies are included rather than something you source yourself.
  • Monthly plan is genuinely cancel-anytime.
  • Unusually clear on its own pages that the product is not FDA-approved.

How they score

What we weighWeightOzariCoby
True monthly cost30%53.7
Price honesty20%4.43.6
Clinical support20%3.93.3
Pharmacy sourcing15%3.83.4
Cancelling15%4.33.7

Ozari Health scores higher overall at 4.4 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

Which suits you

  • Pick Ozari Health if cost is the binding constraint. Over a year the gap is about $1,368, which is real money for the same class of medication.
  • Pick Coby Health if what it does better matters to you — injection supplies are included rather than something you source yourself.
  • Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

For most people starting out, Ozari Health at $125 a month is the more defensible choice on arithmetic alone. Coby Health earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Ozari Health and Coby Health.

How they sit against everyone else

ProgrammePer monthDose-priceOur score
Coreage Rx
Best overall on true monthly cost
$199Flat4.5
Trimi
Lowest flat price with named pharmacies
$125Varies4.6
PlexusDx
Pharmacy transparency and genetic testing
$189Varies4.4
Ozari Health
Lowest advertised semaglutide price
$125Varies4.4
Fifty 410
Prepaid blocks with no subscription
$133Varies4.2
Ivím Health
Unlimited clinician access
$199Varies4
Mochi Health
Insurance concierge support
$278
incl. $79 fee
Varies3.6
Coby Health
Multi-month value with supplies included
$239Varies3.6
Hims & Hers
Widest range of formats
$238
incl. $39 fee
Varies3.5
Ro
Branded medication with insurance help
$448
incl. $149 fee
Varies3.5
Zealthy
Low-cost entry with insurance routing
$216Varies3.5
LifeMD
Insurance coordination
$149Varies3.5

Read next

  • Ozari Health tirzepatide review

    Lowest advertised semaglutide price. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $125 a month.

  • Coby Health tirzepatide review

    Multi-month value with supplies included. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $239 a month.

  • How to spot a bad seller

    The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.

  • The twelve-month cost

    Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.

  • Best programmes if this is your first time

    Ranked on how they price the dose ladder and how reachable support is — the two things that decide whether a beginner stays on treatment.